Decoy Therapeutics is trading at $0.96, down 6.80%, with no company-specific announcement explaining the October 23 decline found in the available news search. - Biotech was reported down 2.08% during the session amid broader risk-off sentiment; this is context, not proof of a direct cause. - Recent company headlines were from September. - Current-session trading volume was not reliably established.